By Semir Vranic, MD, PhD Bosnian Journal of Basic Medical Sciences Editor in Chief Food and Drug Administration (FDA) has just granted accelerated approval to sacituzumab govitecan-hziy (TRODELVY, Immunomedics, Inc.) for the patients with metastatic […]
Background According to World Health Organization (WHO), cancer is the second major source of death worldwide. In general, lung, breast and colorectal cancer are the most prevalent types of cancer. Treatment strategies mainly rely on […]
Apocrine carcinoma of the breast is a rare, primary breast cancer characterized by the apocrine morphology, estrogen receptor-negative and androgen receptor-positive profile with a frequent overexpression of Her-2/neu protein. The frequent presence of PIK3CA mutations […]
Copyright (c) 2019 Association of Basic Medical Sciences of FBIH